CardioTech International calls off Cartika Medical acquisition:
This article was originally published in Clinica
Executive Summary
CardioTech International, the Wilmington, Massachusetts-based contract manufacturer of medical products and developer of cardiovascular devices, has called off its planned acquisition of CarTika Medical. It attributed the decision to the protracted time in obtaining regulatory clearance for its purchase of the Plymouth, Minnesota contract manufacturer, which was announced last November.
You may also be interested in...
Abbott Capitalizes On Pandemic Testing Boom; Device Sales Stay Almost Flat
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
Agios’ Mitapivat Shows Improvement In Regularly Transfused PKD Patients
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
Medtech Industry Favorite Wins Seat On Powerful House E&C Committee
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: